Project Number 3U01AG046152-03S1 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for PATHWAY DISCOVERY, VALIDATION AND COMPOUND IDENTIFICATION FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Category G. Consortia and Public Private Partnerships 2. Public Private Partnership Researcher and Organization Principal Investigator DE JAGER, PHILIP L Principal Investigator First Name PHILIP L Principal Investigator Last Name DE JAGER Awardee Organization BROAD INSTITUTE, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-013: Interdisciplinary Approach to Identification and Validation of Novel Therapeutic Targets for Alzheimer's Disease (R01) FY Overall Cost $1,572,897 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project Related Resources Repository [NIAGADS] ROSMAP GWAS [AMP-AD Knowledge Portal] Pathway discovery, validation and compound identification for Alzheimer's disease
